TY - JOUR JO - EuroIntervention TI - Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III AB - <p class="text-1er-paragraph"><span class="abstracts-titres">Aims:</span> We aimed to assess the safety and performance of the DREAMS 2G scaffold up to 24 months post implant.</p><p class="text-1er-paragraph"><span class="abstracts-titres">Methods and res AU - Haude Michael AU - Ince Hüseyin AU - Kische Stephan AU - Abizaid A. Alexandre AU - Toelg Ralph AU - Lemos Alves Pedro AU - Van Mieghem Nicolas M. AU - Verheye Stefan AU - von Birgelen Clemens AU - Christiansen Høj Evald AU - Wijns William AU - Garcia-Garcia M. Hector AU - Waksman Ron VL - 13 IS - 4 Y1 - 20/07/2017 Y1 - 2017 DOI - 10.4244/EIJ-D-17-00254 SP - 432 EP - 439 KW - bioresorbable scaffolds KW - myocardial infarction KW - stable angina KW - stent thrombosis PB - Europa Digital & Publishing SE - CORONARY INTERVENTIONS UR - https://eurointervention.pcronline.com/article/sustained-safety-and-clinical-performance-of-a-drug-eluting-absorbable-metal-scaffold-up-to-24-months-pooled-outcomes-of-biosolve-ii-and-biosolve-iii SN - 1774-024X ER -